What are the risks of placing a flow-diverting stent to treat Middle Cerebral Artery (MCA) bifurcation aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risks of Flow Diverting Stents for MCA Bifurcation Aneurysms

Flow diverting stents for MCA bifurcation aneurysms carry a high risk of thromboembolic complications (up to 16.7%) and should generally be avoided in favor of surgical clipping, which has better outcomes for this specific anatomical location. 1, 2

Major Risks of Flow Diverting Stents for MCA Bifurcation Aneurysms

Thromboembolic Complications

  • Thromboembolic events occur in 16.7% of MCA bifurcation aneurysms treated with flow diversion 2
  • Ischemic complications confirmed by MRI can occur in up to 43% of patients 3
  • These complications are likely related to:
    • Impaired flow in jailed side branches at the bifurcation
    • Need for dual antiplatelet therapy (which increases hemorrhagic risk)
    • Complex deployment in bifurcation anatomy

Procedural Complications

  • Procedure-related morbidity ranges from 8.6% to 21% 3, 4
  • Risk of arterial rupture during balloon angioplasty when attempting to fully expand the stent 5
  • Technical difficulties with stent deployment at bifurcation points
  • Risk of stent fracture, particularly when manipulating previously stented regions 5

Efficacy Concerns

  • Inferior occlusion rates compared to surgical clipping for MCA bifurcation aneurysms 2
  • Complete occlusion rates vary widely (62-95%) depending on follow-up duration 3, 4
  • Delayed occlusion is common, with many aneurysms requiring 12+ months for complete occlusion 4

Need for Dual Antiplatelet Therapy

  • Higher risk of hemorrhagic complications, particularly ventriculostomy-related hemorrhage in ruptured aneurysms 1
  • Contraindicated in acute subarachnoid hemorrhage when possible 1
  • Compliance issues with long-term antiplatelet therapy

Anatomical Considerations Increasing Risk

Bifurcation Complexity

  • MCA bifurcations are prone to lesion development due to greater shear stress and turbulent blood flow 1
  • Bifurcation lesions are bulky and PCI is complicated by plaque shift in 4.5% to 26% of patients 1
  • Risk of jailing important side branches at the MCA bifurcation

Treatment Strategy Considerations

  • Single-stent techniques have lower TLR rates (<5%) compared to two-stent techniques (up to 25%) 1
  • Y-stent configurations may be required for bifurcation aneurysms, increasing procedural complexity 6
  • Restenosis is often confined to branch ostia (82% of cases) 1

Evidence-Based Recommendations

The 2023 American Heart Association/American Stroke Association guidelines note that:

  • For MCA bifurcation aneurysms specifically, surgical clipping may be superior to endovascular treatment 1
  • Within the cohort of patients >65 years in the ISAT trial, clipping was superior for MCA aneurysms 1
  • Flow diverters should be avoided in the acute phase of ruptured aneurysms whenever possible 1

Risk Mitigation Strategies

  • Careful patient selection is critical - avoid flow diversion for MCA bifurcation aneurysms when surgical clipping is feasible
  • Consider alternative endovascular approaches such as conventional coiling or balloon-assisted techniques
  • If flow diversion is absolutely necessary:
    • Use IVUS for accurate assessment and optimal stent placement
    • Consider single-stent technique when possible
    • Ensure proper dual antiplatelet therapy management
    • Plan for longer angiographic follow-up (12+ months)

Flow diversion for MCA bifurcation aneurysms remains controversial with higher complication rates than traditional approaches, and should be considered only when conventional treatment options are not feasible.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.